Lack of funding halts MRSA study

02/24/2010 | Press and Journal (Aberdeen, Scotland), The

An international study focusing on the development of new treatments for methicillin-resistant Staphylococcus aureus has been stopped as a result of insufficient funds. The study was exploring the potential of a protein called calprotectin, which can inhibit MRSA's food source, as a treatment for the bacteria. The researchers hope their work will be revived in the future.

View Full Article in:

Press and Journal (Aberdeen, Scotland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ